Order results by:
| Issue | Title | |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... a stronger effect on QoL parameters of the frequency of exacerbations in HAMS than in RRMS. Conclusion ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... (RRMS), which is used as an immune reconstitution therapy. A population-based cohort study was conducted ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... independence in daily life, exercise tolerance and quality of life (QoL) in patients with relapsing-remitting ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... (MS), especially for highly active MS (HAMS), in which there are ≥2 exacerbations and corresponding ..." | ||
| Vol 14, No 1 (2022) | Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... reconstitution of highly active multiple sclerosis (HAMS) in general clinical practice. Patients and methods. 34 ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... active MS (HAMS), poses a number of difficult problems for specialists, including not only the choice ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... sclerosis (HAMS). After discussing the characteristics of action of the drug in clinical trials, the authors ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... , and a higher level of fatigue than patients with relapsing-remitting MS (RRMS). Another unfavorable course ..." | ||
| Vol 17, No 1 (2025) | Aggressive multiple sclerosis in the Republic of Bashkortostan | Abstract similar documents |
| K. Z. Bakhtiyarova, U. Sh. Kuzmina, O. V. Lyutov, I. D. Talipova, N. F. Akhmetgaleeva, T. R. Galiullin, M. A. Kutlubaev | ||
| "... and disability, were also used. Results. Rapidly progressive MS (RPMS) and highly active MS (HAMS) were ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... is most pronounced in the initial treatment of relapsing-remitting MS (RRMS) with low or moderate disease ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... MS (RRMS), 9.1±4.2 years in secondary progressive MS (SPMS), and 2.7±1.9 years in primary progressive ..." | ||
| Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
| N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
| "... in the expression of 26 microRNA genes localized in the DLK1-DIO3 locus in men with relapsing-remitting MS (RRMS ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... Objective: to study the pyramidal tract in patients with highly active multiple sclerosis (HAMS ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... (HAMS). According to the instructions for use, oral therapy with cladribine was administered in two ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... % of cases of deterioration). The majority (87%) of patients with relapsing-remitting MS (RRMS) did ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... the Hamilton Anxiety Scale (HAM-A), Hamilton Depression Scale (HAM-D) and Clinical Global Impression Scale (CGI ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... развился ремиттирующий РС (РРС), и тех, у кого длительное время оставался КИС, получены следующие ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... -remitting MS (RRMS). The safety profile of GA 40 mg was completely consistent with the well-known profile ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... -прогрессирующем (ВПРС) фенотипах РС. Пациенты и методы. Обследовано 80 пациентов: с РРС (n=48) и ВПРС (n=32 ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... ремиттирующим рассеянным склерозом (РРС) в стадии ремиссии и пациентов с другими неврологическими заболеваниями ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... Objective: to evaluate the impact of comorbid fibromyalgia (FM) on the quality of life (QoL ..." | ||
| Vol 8, No 2 (2016) | Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients | Abstract similar documents |
| V. A. Parfenov, E. Yu. Solovyeva, L. M. Antonenko, A. B. Lokshina, T. Gorskaya | ||
| "... . Results. Tanakan® therapy resulted in health improvement, as shown by the HAM (Health, Activity, Mood ..." | ||
| Vol 13, No 6 (2021) | Cognitive, emotional and motor disorders and their impact on the postoperative rehabilitation of neurosurgical patients | Abstract similar documents |
| D. Fantalis, I. S. Preobrazhenskaya | ||
| "... in cognitive functions, emotional state, and quality of life (QoL) in the main group 3 and 6 months after ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... of life (QoL) require clarification. Objective: to clarify the impact of dystonia, sensory, affective ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... with PD. Objective: to analyze neuropsychological status and quality of life (QOL) in PD patients ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... of depression on the quality of life (QoL) of MS patients has been little studied. Objective: to study ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... of life (QoL) and daily functioning. Objective: to evaluate the efficacy and safety of the use ..." | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| "... The main goal of epilepsy therapy is to improve the patient’s quality of life (QoL), which ..." | ||
| Vol 5, No 4 (2013) | Clinical and neurological characteristics of patients with somatic referred back pain at the lumbosacral level | Abstract similar documents |
| Natalia Sergeevna Nikolaeva, A B Danilov | ||
| "... questionnaire. The health-activity-mood (HAM), SF-36, and Roland-Morris questionnaires were used to assess ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... Assessment (MoCA); 2) Hamilton Anxiety Rating Scale (HAM-A); 3) Subjective assessment of asthenia scale; 4 ..." | ||
| Vol 7, No 2 (2015) | Brain bioelectrical activity changes in patients with poststroke depression and apathy | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, N. A. Georgievskaya | ||
| "... (DSM-IV) criteria to diagnose depression and the Hamilton depression rating scale (HAM-D) and the mini ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... in the fact that there are various types, such as relapsing-remitting MS (RRMS), primary and secondary ..." | ||
| Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
| D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
| "... Rating Scale (UPDRS), the evaluation also included the quality of life (QoL) scales for patients with PD ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... ) to assess the severity of anxiety and depression and the SF-36 scale to evaluate the quality of life (QoL ..." | ||
| Vol 12, No 3 (2020) | Cervical dystonia: non-motor aspects | Abstract similar documents |
| O. A. Druzhinina, N. G. Zhukova, L. P. Shperling, D. A. Novotnyi | ||
| "... disorders) and quality of life (QOL) in patients with CD. Patients and methods. A total of110 patients (31 ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Surgical and medical treatments for discogenic low back radiculopathy | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. O. Isaikin | ||
| "... scale (NPRS), Oswestry disability index, and quality of life questionnaire (QOL), SF-12] survey ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... with citicoline (Noocil®) on cognitive function and quality of life (QoL)in patients with mild cognitive ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... A decrease in the quality of life (QoL) in cervical dystonia (CD) is often due to anxiety ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... -17 scale) and the impact on quality of life (QOL) according to the SF-36 questionnaire ..." | ||
| Vol 10, No 3 (2018) | Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. I. Isaikin | ||
| "... ) of Quality of Life (QoL) Questionnaire on admission to the clinic, at 7-14 days after treatment (pain ..." | ||
| 1 - 42 of 42 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
